摘要
目的:探讨雷贝拉唑、克拉霉素、替硝唑联合治疗幽门螺杆菌消化性溃疡的效果。方法:选择我科近两年经胃镜证实伴HP感染的消化性溃疡患者168例,将其随机均分为两组,治疗组给予2次/d,口服雷贝拉唑、克拉霉素、替硝唑治疗,对照组采用阿莫西林、甲硝唑常规治疗,比较两组的治疗效果。结果:治疗组和对照组的HP根除率分别为94.5%和73.5%,十二指肠溃疡和胃溃疡的总有效率分别为92.1%和82.1%,两组疗效具有明显差异性。结论:雷贝拉唑、克拉霉素、替硝唑联合治疗幽门螺杆菌(HP)消化性溃疡的疗效确切,Hp根除率高,不良反应轻,值得临床应用。
objective：to ray Bella of clarithromycin tinidazole three joint treatment of Helicobacter pylori in peptic ulcer effect.Methods：the division nearly two years after the gastroscopy with HP infection in168 cases of peptic ulcer patients were randomly divided into two groups,the treatment group was given2 times /D,ray Bella,clarithromycin,ribavirin oral tinidazole therapy with amoxicillin,metronidazole,the control group with conventional therapy,compared with two group of treatment results.Results：the treatment group and the control group HP eradication rates were 94.5% and73.5%,duodenal ulcer and gastric ulcer：the total effective rate were 92.1% and82.1%,the effect of two groups have significant difference.Conclusion：the ray Bella with three joint treatment of Helicobacter pylori（HP） peptic ulcer curative effect,Hp you high eradication rate,less adverse effect,worthy of clinical application.
出处
《求医问药（下半月刊）》
2012年第6期280-281,共2页
Seek Medical and Ask The Medicine
关键词
雷贝拉唑三联合
消化性溃疡
幽门螺杆菌
ray Bella with three combined with you you you you peptic ulcer Helicobacter pylori
